Navigation Links
Susan G. Komen for the Cure(R) Advocacy Alliance Unveils New 'I Vote for the Cure'(R) Web Video
Date:10/27/2008

e access to care, including screening and treatment for breast cancer; (2) reduce disparities in health, education, and income; (3) ensure that the U.S. does not lose momentum in biomedical research and that medical advances make their way to patients; and (4) make high-quality health care more affordable and accessible for all Americans -- http://komenpolicy.org/komenadvocacy/candidates_questionnaires.html.

-- A transcript of remarks made by health care advisors to both campaigns made at a forum Friday, Oct. 3, in Philadelphia, as part of the 24-city Komen Community Challenge campaign to "Close the Gaps" in access to vital screening and treatment -- http://tinyurl.com/54yn4w.

Susan G. Komen for the Cure(R) is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Susan G. Komen Race for the Cure(R), Komen has invested more than $1.2 billion to fulfill its promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world. To continue this progress, Komen for the Cure has pledged to invest another $2 billion in the next ten years.

The Susan G. Komen for the Cure(R) Advocacy Alliance is a sister organization to Susan G. Komen for the Cure(R), and is a voice for change on Capitol Hill, in state legislatures and on the campaign trail. With the help of nearly 200,000 Komen Champions and Komen's network of 122 domestic affiliates, we are aggressively seeking increased funding for research and greater access to screening and treatment. The Komen Advocacy Alliance engages policymakers and leaders at all levels of government to advocate for an increased investment in breast cancer research and greater ac
'/>"/>

SOURCE Susan G. Komen for the Cure Advocacy Alliance
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. PRA International Adds Dr. Susan Stansfield as Executive Vice President
2. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
3. Arthur M. Blank Family Foundation Names Susan Bertonaschi Program Officer, Better Beginnings
4. Forbes Honors Susan G. Komen for the Cure Founder as Trailblazer
5. Celebrities Pledge to Wear Pink, End Breast Cancer Forever With Susan G. Komen for the Cure
6. PNY Technologies and Susan G. Komen for the Cure Partner to Raise Awareness of Breast Cancer
7. Susan G. Komen for the Cure Partners With the Original Butter Bell(R) Crock Developer
8. Susan G. Komen for the Cures Phoenix Affiliate, State Officials, Survivors and Advocates Call for Action on Breast Cancer
9. Susan G. Komen for the Cure Launches Unprecedented Global Expansion Program in 10 Countries
10. In Celebration of Breast Cancer Awareness Month, Susan G. Komen for the Cure San Diego Announces Opportunities for San Diegans to Get Involved in the Fight Against Breast Cancer
11. Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advisory Board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., SEATTLE, Dec. 1 Ce... management,s presentation at the 21st Annual Pipe...ber 1 at 11:00 a.m. Eastern Time will be webcast l...sentation will take place in Holmes 1 at the New Y...eplay after the presentation. , , ...
(Date:12/1/2009)...w-dose radiation from annual mammography screening...etic or familial predisposition to breast cancer, ... meeting of the Radiological Society of North Amer...t cancer, screening is very important, but a caref...graphy for screening young women, particularly und...
(Date:12/1/2009)...gh-frequency ultrasound with elastography can help...onditions, according to a study presented today at... North America (RSNA). , "High-frequency ultraso... the efficiency of skin cancer diagnosis," said le...the Department of Radiology at the University of M...
(Date:12/1/2009)...sults of a randomized, controlled clinical trial p...ogical Society of North America (RSNA) reveal that...n arteries that supply blood to the legs and other...t coronary artery disease. , Peripheral arteria...of fat, cholesterol and other substances, builds u...
(Date:12/1/2009)...MO, December 1, 2009 Adolescent obesity is a majo...ery three children, resulting in 4-5 million overw...shed in the December 2009 issue of the Journal of...valuated differences in weight control behaviors, ...mparing overweight adolescents who lost weight and...
Breaking Medicine News(10 mins):Health News:Mammography may increase breast cancer risk in some high-risk women 2Health News:Special ultrasound accurately identifies skin cancer 2Health News:Severe asymptomatic heart disease may accompany narrowing in leg arteries 2Health News:Investigators identify successful weight control strategies for adolescents 2
...ird flu free nation' status next month, as no case...ry for the last three months, federal Agriculture ... has been no case of avian influenza for the last ...nisation for Animal Health (OIE) on August 10. The...
...al of "user charges" at the All India Institute of... notice of the National Human Rights Commission //...ion on the matter. In a letter to NHRC Chairp...ed to withdraw the "users charges" slapped on poor...
...has been advised by experts in respiratory disease...LABA) drugs are dangerous. LABA drugs are// used t...silis Vassiliou, of the University of Cambridge wh...always be used in addition to other steroid drugs ...
...New Zealand is making certain changes to asthma me...anges are bound to benefit// a significant number ... of the changes include widening the access to ast...r Peter Moodie stressed that these changes will wi...
...a Institute of Medical Sciences' (AIIMS) has acqui...sia, to help in delicate surgeries// at the depart...e acquired the Da Vinci Surgical Robot on July 19 ... and head of urology AIIMS. The machine was ...
..., head of the department of gynecology at the Cath...scientists is working on the disease// endometrios... The disease affects women and results in the gr...nfertility. Statistics show that the disease affec...
Other Medicine News:Health News:AIIMS Acquires Four-Armed Robot to Assist in Surgeries 2
(Date:11/30/2009)...Newswire/ -- Microban International, Ltd., the glo...ction, is pleased to announce their exclusive Nort...gest U.S. manufacturer and distributor of ceramic ...g two new lines of ceramic tile with OutStand Tech...ng silver based technology, in order to create a l...
(Date:11/30/2009)...swire-FirstCall/ -- Covance Inc. (NYSE: CVD ) to...ffray 21st Annual Health Care Conference on Wednes...s may access a live webcast of the presentation at...load any necessary software, please log on 10 minu...nceton, New Jersey, is one of the world,s largest ...
(Date:11/30/2009)...wire/ -- Reportlinker.com announces that a new mar... ,, Cardiac Defibrillators - A Worldwide Marke...ker.com/p0164315/Cardiac-Defibrillators---A-Worldw...vascular disease (CVD) is one of the foremost caus...ivors are prone to arrhythmic disorders, calling t...
Breaking Medicine Technology:Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8Pennsylvania Governor Signs Four Health Care Bills That Will Reduce Costs Improve Access and Quality 48537 1Pennsylvania Governor Signs Four Health Care Bills That Will Reduce Costs Improve Access and Quality 48537 2Pennsylvania Governor Signs Four Health Care Bills That Will Reduce Costs Improve Access and Quality 48537 3Pennsylvania Governor Signs Four Health Care Bills That Will Reduce Costs Improve Access and Quality 48537 4Pennsylvania Governor Signs Four Health Care Bills That Will Reduce Costs Improve Access and Quality 48537 5State to Invest 2411 1 Million in Expansion of Doylestown Hospital 48532 1State to Invest 2411 1 Million in Expansion of Doylestown Hospital 48532 2Ovarian Cancer Breakthrough Heralds New Era of Treatment 48527 1Ovarian Cancer Breakthrough Heralds New Era of Treatment 48527 2
...E)--Mar 26, 2007 - CombinatoRx,Incorporated (NASD... phase 2 clinical trial studying CRx-139 (a synerg...depressant paroxetine),and 3mg prednisolone alone,...trial served two important purposes. One purpose w...alone (a very low dose),in RA and to contrast this...
...--Mar 27, 2007 - Inotek,Pharmaceuticals Corporatio...se 2 clinical data demonstrating the safety of INO...reventative agent for,cardiac reperfusion injury. ...elevated myocardial infarction (STEMI) undergoing,...esentation was,made in a poster session at the Ame...
Other Medicine Technology:CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 2CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 3CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 4CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 5CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 6Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 2Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 3Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 4
11.50mm diameter Corneal Trephine Blades
9.25mm diameter Corneal Trephine Blades
8.50mm diameter Corneal Trephine Blades
8.00mm diameter Corneal Trephine Blades
Medicine Products: